Expense Report Specialist - Newark, CA | Biospace
Get Our FREE Industry eNewsletter

Expense Report Specialist

Depomed, Inc.

Newark, CA
Posted Date:
Position Type:
Full time
Job Code:
Required Education:
Bachelors Degree
Areas of Expertise Desired:

Job Description

City Newark
State California [CA]
Title Expense Report Specialist
Job ID 790XX
Date Added 11/23/2016
Department Finance


Responsible for reviewing and processing expense reports using the Concur Expense Management system to ensure timely approval, payment, and adherence to company policies. Additional responsibilities include supporting the Accounts Payable function, such as processing invoices and researching and resolving invoicing issues.

Under the general supervision of the Senior Manager of Accounting, this position will support the Accounts Payable functions and assist the Finance department with tasks such as:

• Timely review and processing of expense reports in Concur.
• Adherence to travel and entertainment and compliance policies when reviewing expense reports
• Communication and follow up with sales reps and employees at the home office regarding expenses submitted for reimbursement

• Support SOX compliance and external audits, as needed.
• Assist with Accounts Payable functions, such as processing invoices in AX Dynamics ERP system.
• Other accounting and administrative tasks as assigned, such as filing invoices and other accounting records.



• High School graduate or equivalent minimum, some college preferred
• 2+ years’ experience in Accounting or similar field required
• Experience of using Concur reporting system preferred.
• Computer skills including MS Office, ERP database experience (experience of using Microsoft Dynamics AX preferred)
• Superior and accurate data entry skills and attention to detail


• Ability to communicate effectively verbally and in writing
• Ability to apply written and verbal instructions into daily work and to correctly interpret and adhere to policy and procedure
• Ability to work independently and with a team in a fast-paced and high volume environment with emphasis on accuracy and timeliness
• Ability to plan, organize, and prioritize work, to work under pressure and with interruptions

• Integrity
• Decisions & Judgment
• Ownership & Initiative
• Adaptability & Change Readiness
• Teamwork & Collaboration

• Sitting – 70%
• Standing/walking - 30%
• Visual requirements: Able to see and read PC screens and read fine print
• Moderate Carrying and Lifting: Raising objects 15-40 pounds
• Repetitive motions: Approximately 4-6 hours keyboard work a day
• Ability to understand, remember, and apply oral and/or written instructions or other information
• Ability to communicate routine and factual information
• Ability to organize and prioritize own work schedule
• Ability to count accurately and check results for accuracy

About Us

Depomed, Inc. is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions. Founded in 1995, Depomed has successfully executed on strategy of acquiring, integrating and growing differentiated therapeutic products and building each into a strong market presence. The result is a broad portfolio of pain and neurology specialty pharmaceuticals currently comprised of five FDA-approved products. These include Gralise® for the management of Postherpetic Neuralgia (PHN), Cambia® for the acute treatment of migraine attacks, Zipsor® for the relief of mild to moderate acute pain, Lazanda® for the management of breakthrough pain in cancer patients and our most recent addition, the company’s flagship asset, the NUCYNTA® franchise.

Acquired in April 2015 and re-launched in June 2015, the NUCYNTA franchise includes NUCYNTA® ER for the extended management of pain, including neuropathic pain associated with diabetic peripheral neuropathy (DPN) and NUCYNTA® for immediate management of moderate to severe acute pain in adults.

Depomed also has successfully developed and licensed its unique drug-delivery technology, Acuform®. This patented oral-delivery technology allows for the targeted, extended release of pharmaceutical compounds into the upper gastrointestinal tract. The company’s Acuform technology is currently being used in four marketed drugs, including Gralise.

Depomed’s successful execution on strategy and has resulted in solid product revenue growth over the past three years. Located in Newark, California in the East Bay of San Francisco, Depomed is listed on the NASDAQ market under the ticker DEPO and employs approximately 500 people, of which approximately 350 are part of the Commercial organization.

Depomed is an AA/EEO/Veterans/Disabled employer.